RecruitingOBSERVATIONAL

Feasibility of Estimating the Prevalence and Management of Stage 4 CKD the Gard, France

This study in France aims to understand how common severe kidney disease (stages 4 and 5) is in a specific area called the Gard. Researchers will look at anonymous laboratory test results to find out. They also want to see if people with severe kidney disease are seeing kidney specialists (nephrologists) as recommended by French health guidelines. By comparing the lab data with records of patients seen by specialists, the study hopes to figure out if the healthcare system is doing enough to manage severe kidney disease in this region. This will help them understand if people are getting the expert care they need.

At a glance

Status

Recruiting

Sponsor

Centre Hospitalier Universitaire de Nīmes

Enrolment target

3,375

Start

01 Jan 2019

Estimated completion

01 Dec 2025

Renal Insufficiency, Chronic

What is this study about?

Imagine your kidneys are like important filters, cleaning your blood. When they don't work as well, doctors describe this in 'stages.' Stage 4 and 5 means your kidneys are working much less effectively, which is a serious condition.

This study, taking place in a part of France called the Gard, wants to get a better picture of how many people actually have this severe kidney disease. Researchers will look at information from laboratory tests, which often show when someone has kidney problems. They'll use this information to estimate how many people are living with stage 4 or 5 kidney disease in that area.

But it's not just about counting. The study also wants to see if people who have severe kidney disease, according to their lab results, are actually seeing a kidney specialist (called a nephrologist). Leading health authorities in France recommend that people with advanced kidney disease receive care from these specialists. By comparing the lab data with records from nephrologists, the study aims to understand if the healthcare system is successfully connecting patients with the expert care they need. This research is important because it can help improve how care is organised and delivered for people with kidney disease in the future.

Key takeaways

This study looks at anonymous data, not individuals directly.
It aims to understand how many people have severe kidney disease (stages 4 and 5).
It checks if these people are seeing kidney specialists (nephrologists).
The goal is to improve kidney healthcare planning in France.
No one needs to take part; it uses existing information.

Who may be eligible?

This study is looking for information about certain people, rather than asking people to directly take part themselves. They will be using anonymous information that is already available.

The main thing that makes someone's anonymous data included is if they have chronic kidney disease that is at stage 4 or higher. This means their kidneys are not working very well.

There aren't any specific reasons given for why someone's anonymous data would not be included, apart from not having severe kidney disease in the first place.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Do you have chronic kidney disease?
Is your kidney disease considered stage 4 or higher?
Do your lab results show this level of kidney function?
Do you live in the Gard region of France (this study's focus area for data)?

Answer every question to see your result.

What does participation involve?

This study doesn't involve you directly doing anything. You won't have to visit a clinic, take any medication, or have any assessments. The researchers are looking at existing, anonymous data from laboratory tests and records of visits to kidney specialists. This means your personal information (like your name or address) will not be used, and the researchers won't know who you are. This type of study uses information that has already been collected, so you don't need to do anything extra. This study is not asking for new volunteers.

Potential risks and benefits

Since this study only looks at anonymous existing data and doesn't involve anyone directly, there are no direct risks to individuals. You won't be asked to do anything or take any medicine. The potential benefit of this research is that it could help improve how healthcare is planned and delivered for people with kidney disease in France, ensuring more people get the specialist care they need. Because no one is directly involved, the right to withdraw doesn't apply in the usual way; the data used is already anonymous.

Locations (4)

AIDER - Unité de Dialyse d'Alès
Verified postcode
Alès, France· Recruiting
AIDER - Unité de Dialyse de Nîmes, CHU Carémeau
Verified postcode
Nîmes, France· Not yet recruiting
CHU de Nîmes - Hôpital Universitaire Carémeau
Verified postcode
Nîmes, France· Not yet recruiting
Gardialyse
Verified postcode
Nîmes, France· Not yet recruiting

Common questions

What is chronic kidney disease stage 4?

This means your kidneys are quite damaged and are not working as well as they should to filter your blood. It's a serious level of kidney disease.

Will I have to do anything if I have kidney disease?

No, this study uses anonymous existing information. You don't need to do anything or take part in person.

Is my personal information safe?

Yes, your personal details (like your name) will not be used. The study works with anonymous data, meaning no one can identify you.

What is a nephrologist?

A nephrologist is a doctor who specialises in kidney health and kidney diseases.

How might this study help people?

It could help healthcare planners understand if people with serious kidney disease are getting the specialist care they need, potentially improving future services.

How to find out more

Olivier Moranne, MD, PhD

olivier.moranne@chu-nimes.fr +33.(0)4.66.68.31.49 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.